In the present study, we demonstrated that c-Src is activated in experimental proliferative glomerulonephritis and that the reduction of c-Src ameliorates the development of glomerulosclerosis by blocking of the Smad1 signal transduction pathway. The gene discussed is SRC; the disease is proliferative glomerulonephritis.